Advanced Search

Technical Analysis for GMTX - Gemini Therapeutics, Inc.

Grade Last Price % Change Price Change
D 11.3 0.53% 0.06
GMTX closed up 2.09 percent on Friday, April 16, 2021, on 72 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical GMTX trend table...
Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.53%
Wide Bands Range Expansion 0.53%
Oversold Stochastic Weakness 0.53%
New 52 Week Closing Low Bearish 2.63%
Stochastic Buy Signal Bullish 2.63%
Volume Surge Other 2.63%
New 52 Week Low Weakness 2.63%
Wide Bands Range Expansion 2.63%
Down 3 Days in a Row Weakness 2.63%
Down 4 Days in a Row Weakness 2.63%
Older End-of-Day Signals for GMTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 4 minutes ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 3% about 5 hours ago
Down 2 % about 5 hours ago
Down 1% about 5 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Gemini Therapeutics, Inc., a precision medicine company, focuses on the development of new therapies for patients suffering from dry AMD and linked diseases. The company was founded in 2015 and is based in Cambridge, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Diseases Precision Medicine Pharmaceutical Companies Vertex Pharmaceuticals

Is GMTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 13 Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Apr 12 Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
Mar 29 Gemini Therapeutics reports FY results
Mar 29 Gemini Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
Mar 2 Gemini Therapeutics: Precision Medicine Company Focused On Dry AMD
Feb 24 The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 23 The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Feb 19 Gemini Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference
Feb 10 Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103 in Dry Age-Related Macular Degeneration (AMD) in Patients with High-Risk Genetic Variants
Feb 9 Gemini Therapeutics Appoints Brian Piekos as Chief Financial Officer
See more GMTX news...

Indicators

Indicator Value
52 Week High 19.085
52 Week Low 10.57
Average Volume 282,373
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 13.96
10-Day Moving Average 12.56
Average True Range 1.32
ADX 16.19
+DI 12.31
-DI 22.88
Chandelier Exit (Long, 3 ATRs ) 14.70
Chandelier Exit (Short, 3 ATRs ) 14.52
Upper Bollinger Band 17.58
Lower Bollinger Band 10.33
Percent B (%b) 0.13
BandWidth 51.99
MACD Line -0.92
MACD Signal Line -0.51
MACD Histogram -0.4108
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.91
Resistance 3 (R3) 12.92 12.38 12.63
Resistance 2 (R2) 12.38 11.95 12.37 12.54
Resistance 1 (R1) 11.81 11.69 11.54 11.80 12.45
Pivot Point 11.26 11.26 11.13 11.26 11.26
Support 1 (S1) 10.69 10.84 10.42 10.68 10.03
Support 2 (S2) 10.15 10.57 10.14 9.94
Support 3 (S3) 9.58 10.15 9.85
Support 4 (S4) 9.57